CRY News and Press, CryoLife Inc. From 06/18/20

CryoLife (NYSE: CRY ) intends to offer $100M aggregate principal amount of convertible senior notes due 2025 in a private placement. More news on: CryoLife, Inc., Healthcare stocks news, , Read more ...

ATLANTA , June 18, 2020 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market conditions and other factors, $100,000,000 aggre...

A recovery in the medical technology sector likely began in May, Needham says, coming off what looks to be a trough in April for the decline in medical procedures. More news on: CryoLife, Inc., Zimmer Biomet Holdings, Inc., Healthcare stocks news, Notable Calls Read more ...

ATLANTA , May 7, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has initiated enrollment in the PROACT Xa clinical trial, a prospective, randomized, trial to determine if patients with an...

CryoLife, Inc. (CRY) Q1 2020 Earnings Conference Call April 30, 2020 04:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Pat Mackin - CEO Ashley Lee - CFO Conference Call Participants Jason Mills - Canaccord Genuity David Saxon - Needham and Company Suraj Kali...

Image source: The Motley Fool. CryoLife   (NYSE: CRY) Q1 2020 Earnings Call Apr 30, 2020 , 4:30 p.m. ET Operator Continue reading

CryoLife (NYSE: CRY ): Q1 Non-GAAP EPS of -$0.08 misses by $0.09 ; GAAP EPS of -$0.18. More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ATLANTA , April 30, 2020 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% ...

ATLANTA , April 16, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 first quarter financial results will be released on Thursday, April 30, 2020 after the market closes.  ...

ATLANTA , April 1, 2020 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today it has taken multiple steps to focus on the health and welfare of its employees, patients, and customers. "...